MRSA is a contagious, antibiotic-resistant staph infection that can become dangerous. Find out the causes and symptoms, and when to call your doctor.

The global methicillin-resistant staphylococcus aureus drugs market is expected to grow from $2.15 billion in 2022 to $2.26 billion in 2023 at a compound annual growth rate (CAGR) of 5.4%.

MRSA stands for methicillin-resistant Staphylococcus aureus. It is one of many strains of a bacterium called Staphylococcus aureus -- or staph, for short. Staph bacteria are common on skin and ...

Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033" report has been added to ResearchAndMarkets.com's ...

Staphylococcus aureus is a bacterium that commonly grows on the skin. If levels become too high, a staph infection may develop. Methicillin-resistant Staphylococcus aureus (MRSA) causes a type of ...

Wayne Lukas had been battling a severe Methicillin-resistant Staphylococcus aureus (MRSA) blood infection. He died on ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that does not respond to several antibiotics. Depending on which part of the body it affects, symptoms range from skin infections ...

Bedbugs may be able to acquire and transmit methicillin-resistant Staphylococcus aureus (MRSA), according to a study published in the Journal of Infectious Diseases. Here's what to know.

Methicillin-resistant Staphylococcus aureus (MRSA) is a serious bacterial infection that is resistant to most antibiotic treatments. Healing is possible but severe infections may become chronic or ...

The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing market is estimated to account for USD 4.3 billion in 2025. It is anticipated to grow at a CAGR of 4.2% during the assessment ...

During the COVID pandemic, methicillin-resistant Staphylococcus aureus (MRSA) infections in acute care hospitals rose steeply, despite a decrease of infections before the pandemic, the Society for ...

The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Industry has valued at US$ 3.9 billion in 2022 and is anticipated to grow to US$ 5.5 billion by 2030, with sales revenue set to ...